Passage Bio, Inc.
PASG
$0.3117
-$0.0145-4.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.99M | 26.56M | 27.49M | 29.05M | 30.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.17M | 69.34M | 76.72M | 85.17M | 91.70M |
| Operating Income | -65.17M | -69.34M | -76.72M | -85.17M | -91.70M |
| Income Before Tax | -64.77M | -68.80M | -76.57M | -84.44M | -102.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.77 | -68.80 | -76.57 | -84.44 | -102.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.77M | -68.80M | -76.57M | -84.44M | -102.06M |
| EBIT | -65.17M | -69.34M | -76.72M | -85.17M | -91.70M |
| EBITDA | -62.09M | -66.17M | -73.35M | -81.62M | -87.98M |
| EPS Basic | -1.07 | -1.17 | -1.36 | -1.53 | -1.87 |
| Normalized Basic EPS | -0.62 | -0.68 | -0.78 | -0.90 | -0.97 |
| EPS Diluted | -1.08 | -1.18 | -1.36 | -1.54 | -1.87 |
| Normalized Diluted EPS | -0.62 | -0.68 | -0.78 | -0.90 | -0.97 |
| Average Basic Shares Outstanding | 241.60M | 234.62M | 227.65M | 220.65M | 218.97M |
| Average Diluted Shares Outstanding | 241.60M | 234.62M | 227.65M | 220.65M | 218.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |